Laura Craft, President with OnPoint Analytics, Inc., to Speak at The Knowledge Group’s Emerging Antitrust Issues in Pharmaceuticals and Life Sciences Sectors Webcast
New York, NY, September 20, 2019 --(PR.com)-- The Knowledge Group Live Webcast Series, the leading producer of regulatory focused webcasts, has announced today that Laura Craft, President with OnPoint Analytics, Inc., will speak at The Knowledge Group’s webcast entitled: “Emerging Antitrust Issues in Pharmaceuticals and Life Sciences Sectors.” This event is scheduled for Tuesday, November 19, 2019 from 12:00 pm to 2:00 pm (ET).
For further details, please visit: https://www.theknowledgegroup.org/webcasts/pharmaceuticals-and-life-sciences-sector/
About Laura Craft
Laura Craft is co-founder of OnPoint Analytics, Inc., an economic and statistical consulting firm specializing in antitrust, pharmaceutical industry, health care, class action and intellectual property litigation. She has overseen the development of expert testimony in more than sixty pharmaceutical industry cases, spanning almost all major classes of drug treatments. Her recent publications include the book Empirical Challenges in Pharma Litigation. Recent antitrust cases in which she has served as testifying expert include In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation (End Payor Actions); In re: Niaspan Antitrust Litigation (End Payor Actions); In re: Loestrin Antitrust Litigation (End Payor Actions); and In re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation.
About OnPoint Analytics, Inc.
OnPoint Analytics is an economic, statistical and financial consulting firm located in the San Francisco Bay Area. It is known for its intensive data analyses in complex litigation, including antitrust and other forms of unfair competition, intellectual property, and breach of contract. Much of OnPoint’s work involves the health care industry, spanning network creation, premium pricing, and reimbursement practices. OnPoint has a dedicated team addressing pharmaceutical products and markets. Its drug cases include antitrust class actions, patent litigation, injunction proceedings, and a wide range of competition disputes including interference with contract to eliminate competitor products.
Abstract
Antitrust violations in the pharmaceutical and life sciences industry continue to proliferate in recent years, resulting to intensified enforcement actions and increased litigation. Issues on pricing transparency, complex distribution chain, and third-party payers are significant factors contributory to this upward trend. Compliance has never been more critical.
To mitigate compliance issues and challenges, it is imperative that counsel to businesses are in the know of the latest trends and developments in this evolving regulatory paradigm. They must be able to identify effective strategies to guide their clients from further antitrust disputes.
Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide an in-depth discussion of the emerging antitrust enforcement actions in the pharmaceutical and life sciences industry. Speakers will dig deeper as they offer risk mitigations strategies and best practices in this increasingly complex legal climate.
This Live Webcast will discuss the following:
- Antitrust Issues and Disputes - Statistics
- Emerging Regulatory Enforcement Actions
- Risk Mitigation Techniques
- Best Compliance Practices
- What Lies Ahead
About The Knowledge Group Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
For further details, please visit: https://www.theknowledgegroup.org/webcasts/pharmaceuticals-and-life-sciences-sector/
About Laura Craft
Laura Craft is co-founder of OnPoint Analytics, Inc., an economic and statistical consulting firm specializing in antitrust, pharmaceutical industry, health care, class action and intellectual property litigation. She has overseen the development of expert testimony in more than sixty pharmaceutical industry cases, spanning almost all major classes of drug treatments. Her recent publications include the book Empirical Challenges in Pharma Litigation. Recent antitrust cases in which she has served as testifying expert include In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation (End Payor Actions); In re: Niaspan Antitrust Litigation (End Payor Actions); In re: Loestrin Antitrust Litigation (End Payor Actions); and In re: Restasis (Cyclosporine Ophthalmic Emulsion) Antitrust Litigation.
About OnPoint Analytics, Inc.
OnPoint Analytics is an economic, statistical and financial consulting firm located in the San Francisco Bay Area. It is known for its intensive data analyses in complex litigation, including antitrust and other forms of unfair competition, intellectual property, and breach of contract. Much of OnPoint’s work involves the health care industry, spanning network creation, premium pricing, and reimbursement practices. OnPoint has a dedicated team addressing pharmaceutical products and markets. Its drug cases include antitrust class actions, patent litigation, injunction proceedings, and a wide range of competition disputes including interference with contract to eliminate competitor products.
Abstract
Antitrust violations in the pharmaceutical and life sciences industry continue to proliferate in recent years, resulting to intensified enforcement actions and increased litigation. Issues on pricing transparency, complex distribution chain, and third-party payers are significant factors contributory to this upward trend. Compliance has never been more critical.
To mitigate compliance issues and challenges, it is imperative that counsel to businesses are in the know of the latest trends and developments in this evolving regulatory paradigm. They must be able to identify effective strategies to guide their clients from further antitrust disputes.
Join a panel of key thought leaders and practitioners assembled by The Knowledge Group as they provide an in-depth discussion of the emerging antitrust enforcement actions in the pharmaceutical and life sciences industry. Speakers will dig deeper as they offer risk mitigations strategies and best practices in this increasingly complex legal climate.
This Live Webcast will discuss the following:
- Antitrust Issues and Disputes - Statistics
- Emerging Regulatory Enforcement Actions
- Risk Mitigation Techniques
- Best Compliance Practices
- What Lies Ahead
About The Knowledge Group Live Webcast Series
The Knowledge Group was established with the mission to produce unbiased, objective, and educational live webinars that examine industry trends and regulatory changes from a variety of different perspectives. The goal is to deliver a unique multilevel analysis of an important issue affecting business in a highly focused format. To contact or register for an event, please visit: http://theknowledgegroup.org/
Contact
The Knowledge Group
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Thomas LaPointe, Jr., Executive Director
646-844-0200
www.theknowledgegroup.org
Therese Lumbao, Director
Account Management & Member Services
tlumbao@knowledgecongress.org
Contact
Categories